Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001041062-25-000097·AVADEL PHARMACEUTICALS PLC
Schedule 13G ownership disclosure
AVADEL PHARMACEUTICALS PLC
Common Shares · CUSIP: G29687103
Event date: 2025-03-31
- Filing-level shares
- 5,670,682.00
- Percent of class
- 5.9%
- BRANDES INVESTMENT PARTNERS, LP
Shares: 5,670,682.00 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001041062-25-000097
- Form type
- SCHEDULE 13G
- Filer
- AVADEL PHARMACEUTICALS PLC
- CIK
- CIK 1012477
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership